How I Treat Older Patients With Acute Myeloid Leukemia

被引：8
作者：
Arellano, Martha [1 ]
Carlisle, Jennifer Wilkinson [2 ]
机构：
[1] Emory Univ, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA
[2] Emory Univ, Hematol & Med Oncol Fellowship Training Program, Atlanta, GA 30322 USA
来源：
CANCER | 2018年 / 124卷 / 12期
关键词：
ACUTE MYELOGENOUS LEUKEMIA; HEMATOPOIETIC-CELL TRANSPLANTATION; INTERMEDIATE-DOSE CYTARABINE; CONVENTIONAL CARE REGIMENS; ACUTE MYELOCYTIC-LEUKEMIA; COLONY-STIMULATING FACTOR; PHASE-III TRIAL; GEMTUZUMAB OZOGAMICIN; INDUCTION THERAPY; G-CSF;
D O I：
10.1002/cncr.31347
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：2472 / 2483
页数：12
相关论文
共 119 条
[1]   Mutations in epigenetic modifiers in the pathogenesis and therapy of acute myeloid leukemia [J].
Abdel-Wahab, Omar ;
Levine, Ross L. .
BLOOD, 2013, 121 (18) :3563-3572
[2]   Outcomes and Quality of Care in Acute Myeloid Leukemia Over 40 Years [J].
Alibhai, Shabbir M. H. ;
Leach, Marc ;
Minden, Mark D. ;
Brandwein, Joseph .
CANCER, 2009, 115 (13) :2903-2911
[3]   MITOXANTRONE, ETOPOSIDE, AND INTERMEDIATE-DOSE CYTARABINE - AN EFFECTIVE AND TOLERABLE REGIMEN FOR THE TREATMENT OF REFRACTORY ACUTE MYELOID-LEUKEMIA [J].
AMADORI, S ;
ARCESE, W ;
ISACCHI, G ;
MELONI, G ;
PETTI, MC ;
MONARCA, B ;
TESTI, AM ;
MANDELLI, F .
JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (07) :1210-1214
[4]   Gemtuzumab Ozogamicin Versus Best Supportive Care in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Unsuitable for Intensive Chemotherapy: Results of the Randomized Phase III EORTC-GIMEMA AML-19 Trial [J].
Amadori, Sergio ;
Suciu, Stefan ;
Selleslag, Dominik ;
Aversa, Franco ;
Gaidano, Gianluca ;
Musso, Maurizio ;
Annino, Luciana ;
Venditti, Adriano ;
Voso, Maria Teresa ;
Mazzone, Carla ;
Magro, Domenico ;
De Fabritiis, Paolo ;
Muus, Petra ;
Alimena, Giuliana ;
Mancini, Marco ;
Hagemeijer, Anne ;
Paoloni, Francesca ;
Vignetti, Marco ;
Fazi, Paola ;
Meert, Liv ;
Ramadan, Safaa Mahmoud ;
Willemze, Roel ;
de Witte, Theo ;
Baron, Frederic .
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (09) :972-+
[5]   Randomized trial of two schedules of low-dose gemtuzumab ozogamicin as induction monotherapy for newly diagnosed acute myeloid leukaemia in older patients not considered candidates for intensive chemotherapy. A phase II study of the EORTC and GIMEMA leukaemia groups (AML-19) [J].
Amadori, Sergio ;
Suciu, Stefan ;
Selleslag, Dominik ;
Stasi, Roberto ;
Alimena, Giuliana ;
Baila, Liliana ;
Rizzoli, Vittorio ;
Borlenghi, Erika ;
Gaidano, Gianluca ;
Magro, Domenico ;
Torelli, Giuseppe ;
Muus, Petra ;
Venditti, Adriano ;
Cacciola, Emma ;
Lauria, Francesco ;
Vignetti, Marco ;
de Witte, Theo .
BRITISH JOURNAL OF HAEMATOLOGY, 2010, 149 (03) :376-382
[6]   Enasidenib induces acute myeloid leukemia cell differentiation to promote clinical response [J].
Amatangelo, Michael D. ;
Quek, Lynn ;
Shih, Alan ;
Stein, Eytan M. ;
Roshal, Mikhail ;
David, Muriel D. ;
Marteyn, Benoit ;
Farnoud, Noushin Rahnamay ;
de Botton, Stephane ;
Bernard, Olivier A. ;
Wu, Bin ;
Yen, Katharine E. ;
Tallman, Martin S. ;
Papaemmanuil, Elli ;
Penard-Lacronique, Virginie ;
Thakurta, Anjan ;
Vyas, Paresh ;
Levine, Ross L. .
BLOOD, 2017, 130 (06) :732-741
[7]  
[Anonymous], BLOOD
[8]   Age and acute myeloid leukemia [J].
Appelbaum, FR ;
Gundacker, H ;
Head, DR ;
Slovak, ML ;
Willman, CL ;
Godwin, JE ;
Anderson, JE ;
Petersdorf, SH .
BLOOD, 2006, 107 (09) :3481-3485
[9]   The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia [J].
Arber, Daniel A. ;
Orazi, Attilio ;
Hasserjian, Robert ;
Thiele, Jurgen ;
Borowitz, Michael J. ;
Le Beau, Michelle M. ;
Bloomfield, Clara D. ;
Cazzola, Mario ;
Vardiman, James W. .
BLOOD, 2016, 127 (20) :2391-2405
[10]   High-dose cytarabine induction is well tolerated and active in patients with de novo acute myeloid leukemia older than 60 years [J].
Arellano, Martha ;
Winton, Elliott ;
Pan, Lin ;
Lima, Lisa ;
Tighiouart, Mourad ;
Bhalla, Kapil ;
Heffner, Leonard T. ;
Neely, Jessica ;
Hutcherson, Donald ;
McLemore, Morgan ;
Langston, Amelia ;
Khoury, H. Jean .
CANCER, 2012, 118 (02) :428-433
12345678910